Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross-sectional cohort: Cardiovascular Injury due to Tobacco Use study

BMJ Open

Volumn 8, Issue 3, 2018, Pages

  Keith, Rachel J ^a,b   Fetterman, Jessica L ^c,d   Riggs, Daniel W ^a,b   O'Toole, Timothy ^a,b   Nystoriak, Jessica L ^a,b   Holbrook, Monika ^c,d   Lorkiewicz, Pawel ^a,b   Bhatnagar, Aruni ^a,b   Defilippis, Andrew P ^a,b   Hamburg, Naomi M ^c,d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

cardiovascular risk; cigarettes; electronic cigarette; smoking; tobacco; vascular injury

Indexed keywords

1 BROMOPROPANE; 1,3 BUTADIENE; ACETALDEHYDE; ACROLEIN; ACRYLAMIDE; ACRYLONITRILE; ANABASINE; ANATABINE; BIOLOGICAL MARKER; CARBON DISULFIDE; CROTONALDEHYDE; CYANIDE; ETHYLBENZENE; ETHYLENE OXIDE; FORMALDEHYDE; N,N DIMETHYLFORMAMIDE; NICOTINE; PROPYLENE OXIDE; STYRENE; TETRACHLOROETHYLENE; TOLUENE; TRICHLOROETHYLENE; UNCLASSIFIED DRUG; VINYL CHLORIDE; VOLATILE ORGANIC COMPOUND; XYLENE;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; HEART FUNCTION TEST; HUMAN; METHODOLOGY; NON INVASIVE PROCEDURE; NORMAL HUMAN; OBSERVATIONAL STUDY; PARTICULATE MATTER; SMOKING; TOBACCO; TOBACCO USE; URINALYSIS; YOUNG ADULT; ELECTRONIC CIGARETTE; MASSACHUSETTS; MIDDLE AGED; RISK FACTOR;

ADULT; BOSTON; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; RESEARCH DESIGN; RISK FACTORS; SMOKING; TOBACCO; TOBACCO PRODUCTS; TOBACCO USE; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 85053025567     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-019850     Document Type: Article

References (48)

1. Rostron B. Smoking-attributable mortality by cause in the United States: Revising the CDC's data and estimates. Nicotine Tob Res 2013;15:238-46.
2. Morris PB, Ference BA, Jahangir E, et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: Clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American College of Cardiology. J Am Coll Cardiol 2015;66:1378-91.
3. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol 2012;25:794-810.
4. Ghilarducci DP, Tjeerdema RS. Fate and effects of acrolein. Rev Environ Contam Toxicol 1995;144:95-146.
5. Dong JZ, Moldoveanu SC. Gas chromatography-mass spectrometry of carbonyl compounds in cigarette mainstream smoke after derivatization with 2,4-dinitrophenylhydrazine. J Chromatogr A 2004;1027:25-35.
6. Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008;10:1773-82.
7. Awe SO, Adeagbo AS, D'Souza SE, et al. Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism. Toxicol Appl Pharmacol 2006;217:266-76.
8. Conklin DJ, Barski OA, Lesgards JF, et al. Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicol Appl Pharmacol 2010;243:1-12.
9. Conklin DJ, Bhatnagar A, Cowley HR, et al. Acrolein generation stimulates hypercontraction in isolated human blood vessels. Toxicol Appl Pharmacol 2006;217:277-88.
10. Conklin DJ, Haberzettl P, Prough RA, et al. Glutathione-Stransferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am J Physiol Heart Circ Physiol 2009;296:H1586-97.
11. Ismahil MA, Hamid T, Haberzettl P, et al. Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2011;301:H2050-60.
12. O'Toole TE, Hellmann J, Wheat L, et al. Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res 2010;107:200-3.
13. O'Toole TE, Zheng YT, Hellmann J, et al. Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages. Toxicol Appl Pharmacol 2009;236:194-201.
14. Sithu SD, Srivastava S, Siddiqui MA, et al. Exposure to acrolein by inhalation causes platelet activation. Toxicol Appl Pharmacol 2010;248:100-10.
15. Srivastava S, Sithu SD, Vladykovskaya E, et al. Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011;215:301-8.
16. Tsakadze NL, Srivastava S, Awe SO, et al. Acrolein-induced vasomotor responses of rat aorta. Am J Physiol Heart Circ Physiol 2003;285:H727-34.
17. Wang GW, Guo Y, Vondriska TM, et al. Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxideinduced PKCepsilon signaling and cardioprotection. J Mol Cell Cardiol 2008;44:1016-22.
18. Wheat LA, Haberzettl P, Hellmann J, et al. Acrolein inhalation prevents vascular endothelial growth factor-induced mobilization of Flk-1+/Sca-1+ cells in mice. Arterioscler Thromb Vasc Biol 2011;31:1598-606.
19. WHO study group on tobacco product regulation. Report on the scientific basic of tobacco product regulation: Fourth report of a WHO study group. World Health Organ Tech Rep Ser 2012:1-83.
20. De Woskin R, Greenberg M, Pepelko W, et al. Toxicological review of acrolein (cas no. 107-02-08) in support of summary information on the integrated risk information system (Iris). Washington, DC: US Environmental Protection Agency, 2003.
21. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: Effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014;16:1319-26.
22. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-9.
23. Wang P, Chen W, Liao J, et al. A device-independent evaluation of carbonyl emissions from heated electronic cigarette solvents. PLoS One 2017;12:e0169811.
24. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
25. Parsons VL, Moriarity C, Jonas K, et al. Design and estimation for the national health interview survey, 2006-2015. Vital Health Stat 2 2014:1-53.
26. Raysoni AU, Stock TH, Sarnat JA, et al. Evaluation of VOC concentrations in indoor and outdoor microenvironments at nearroad schools. Environ Pollut 2017;231(Pt 1):681-93.
27. Boyle EB, Viet SM, Wright DJ, et al. Assessment of exposure to VOCs among Pregnant Women in the National Children's Study. Int J Environ Res Public Health 2016;13:376.
28. Jain RB. Distributions of selected urinary metabolites of volatile organic compounds by age, gender, race/ethnicity, and smoking status in a representative sample of U.S. adults. Environ Toxicol Pharmacol 2015;40:471-9.
29. Sarkar M, Muhammad-Kah R, Liang Q, et al. Evaluation of spot urine as an alternative to 24h urine collection for determination of biomarkers of exposure to cigarette smoke in adult smokers. Environ Toxicol Pharmacol 2013;36:108-14.
30. Benowitz NL, Jacob P. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993;53:316-23.
31. Fuhr U, Boettcher MI, Kinzig-Schippers M, et al. Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 2006;15:266-71.
32. DeJarnett N, Conklin DJ, Riggs DW, et al. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc 2014;3:e000934.
33. Alwis KU, Blount BC, Britt AS, et al. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta 2012;750:152-60.
34. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1-7.
35. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy? Arterioscler Thromb Vasc Biol 2006;26:257-66.
36. DeJarnett N, Yeager R, Conklin DJ, et al. Residential proximity to major roadways is associated with increased levels of AC133+ circulating angiogenic cells. Arterioscler Thromb Vasc Biol 2015;35:2468-77.
37. Poredos P, Orehek M, Tratnik E. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology 1999;50:201-8.
38. Heiss C, Amabile N, Lee AC, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: Sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 2008;51:1760-71.
39. Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: From research into clinical practice. Circulation 2012;126:753-67.
40. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004;109:613-9.
41. Vita JA. Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol 2002;359:186-200.
42. Mitchell GF, Guo CY, Benjamin EJ, et al. Cross-sectional correlates of increased aortic stiffness in the community: The Framingham Heart Study. Circulation 2007;115:2628-36.
43. Duffy SJ, Keaney JF, Holbrook M, et al. Short-A nd long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001;104:151-6.
44. Benowitz NL, Dains KM, Dempsey D, et al. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res 2011;13:772-83.
45. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief 2015:1-8.
46. Maher JE, Boysun MJ, Rohde K, et al. Are latinos really less likely to be smokers? Lessons from Oregon. Nicotine Tob Res 2005;7:283-7.
47. Barbeau EM, Krieger N, Soobader MJ. Working class matters: Socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health 2004;94:269-78.
48. Giskes K, Kunst AE, Benach J, et al. Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health 2005;59:395-401.